The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ardelyx, Inc(NASDAQ:ARDX) 
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irr...
Website: http://www.ardelyx.com
Founded: 2007
Full Time Employees: 88
Sector: Healthcare
Industry: Biotechnology
Ardelyx Days Payable Outstanding ttm (DPO)
Ardelyx Days Receivable Outstanding ttm (DSO)
Ardelyx Days Inventory Outstanding ttm (DIO)
Ardelyx Op Cashflow Per Share ttm
Ardelyx Free Cashflow Per Share ttm
Ardelyx Cash Per Share ttm
Ardelyx P/S ratio ttm
Ardelyx (GAAP) P/E ratio ttm
Ardelyx P/B ratio ttm
No extra charts and metrics for this ticker.